Recruitment Maneuvers in ARDS: Effects on Respiratory Function and Inflammatory Markers.
NCT ID: NCT00263146
Last Updated: 2017-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
30 participants
INTERVENTIONAL
2005-09-30
2006-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Low tidal-volume ventilation (6 mL/kg) with low plateau pressure (\< 30 cm H2O) has been proved to decrease mortality when compared with more conventionnal high-volume (12 mL/kg) ventilation.Moreover, this lung-protective approach decrease lung annd systemic inflammation.
Using recruitment maneuvers (i.e. the application during a short time of high pressures with the intention to re-open the lung, followed by an increase of PEEP-level to keep the lung open, in an attempt to decrease the alveolar shear-stress) has been proposed to improve oxygen and to reduce bio-trauma.
However, the effect of such maneuvers on the inflammatory response and on the evolution of ARDS remains unknown.
Therefore we have planned a randomized, monocentric, controlled trial consisting of the comparison of two approaches of mechanical ventilation in Acute Lung Injury. This trial will include 30 hemodynamically stable patients fulfilling the ALI or ARDS criteria defined by the US and European Consensus Conference.
They will be randomized in two groups: standard low-volume ventilation vs. recruitment maneuvers.
The main objective of our study is to compare both ventilatory strategies in termes of lung and systemic inflammation.
The primary outcome measures will be the proteasis activity as measured in broncho alveolar fluid (BAL) and pro- and antiinflammatory cytokines activity as measured in the BAL and in the blood. Two samples (BAL and blood) will be obtained at a 48-72 hours interval. In the recruitment maneuver group, the first BAL will be obtained two hours before the maneuver.
Secondary outcome measures will be gaz exchange, respiratory mechanics, systemic hemodynamics and visceral dysfunction scores.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimization of PEEP for Alveolar Recruitment in ARDS
NCT01949272
Lung Imaging for Ventilatory Setting in ARDS
NCT02149589
The Strategy of "Pulmonary Opening by Titration of Positive End-expiratory Pressure" Means of a Pulmonary Recruitment Maneuver in Patients With Acute Respiratory Distress Syndrome: for Which Patients?
NCT04028336
Comparison of the Hemodynamic Safety of Two Common Alveolar Recruitment Manoeuvres With Regard to Cardiac Output in a Surgical Intensive Care Unit
NCT02805036
Effect of Prone Positioning on Mortality in Patients With Mild to Moderate Acute Respiratory Distress Syndrome.
NCT05056090
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
recruitment maneuver
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* hospitalization in the ICU
* under mechanical ventilation
* Acute Lung Injury (ALI)criteria
* first week of ALI
* hemodynamic stability (mAP \> 75 mmHg since one hour)
* informed consent signed (patient or relatives)
Exclusion Criteria
* obesity (BMI \> 40 kg/M2)
* high probability of D-28 death
* severe burn injury
* severe hepatic cirrhosis (Child-Pugh C)
* aplasia
* HIV or CHV infection
* use of more than 0.5 mg/kg of steroïds
* immunosuppressor agents
* hemopathy
* contra indications for BAL
* contra indications for recruitment maneuvers
* baro-traumatism
* left cardiac failure
* chronic respiratory failure
* inclusion in another study during the past month
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Tours
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gilles Rival, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Tours
Pierre-Francois Dequin, MD, PhD
Role: STUDY_CHAIR
University Hospital of Tours
Francis Gauthier, PhD
Role: STUDY_DIRECTOR
Inserm U-618
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Tours
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ARAMIS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.